@article {Belheouane2021.04.30.21256380, author = {Meriem Belheouane and Britt M. Hermes and Nina Van Beek and Sandrine Benoit and Philippe Bernard and Kossara Drenovska and Sascha Gerdes and Regine Gl{\"a}ser and Matthias Goebeler and Claudia G{\"u}nther and Anabelle von Georg and Christoph M. Hammers and Maike M. Holtsche and Bernhard Homey and Orsolya N. Horv{\'a}th and Franziska H{\"u}bner and Beke Linnemann and Pascal Joly and Dalma M{\'a}rton and Aikaterini Patsatsi and Claudia Pf{\"o}hler and Mikl{\'o}s S{\'a}rdy and Laura Huilaja and Snejina Vassileva and Detlef Zillikens and Saleh Ibrahim and Christian D. Sadik and Enno Schmidt and John F. Baines}, title = {Characterization of the skin microbiota in bullous pemphigoid patients and controls reveals novel microbial indicators of disease}, elocation-id = {2021.04.30.21256380}, year = {2021}, doi = {10.1101/2021.04.30.21256380}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Bullous pemphigoid (BP) is an autoimmune skin blistering disease afflicting mostly the elderly and is associated with significantly increased mortality. Here, we conducted the most extensive sampling effort of skin microbiota in BP to date to analyze whether intra-individual, body-site-specific, and/or geographical variation contributes to the emergence of BP. We find marked differences in the skin microbiota of BP patients compared to that of control subjects, and moreover that disease status rather than skin biogeography governs the skin microbiota composition in BP. Our data reveal a discernible transitional stage between normal and diseased skin in BP characterized by a loss of protective microbiota and an increase in sequences matching Staphylococcus aureus, a known inflammation-promoting species. Notably, S. aureus is ubiquitously associated with disease status, suggesting that this taxon is an important indicator of BP. Importantly, differences in a few key indicator taxa are able to reliably discriminate between BP patients and controls, characterized by their opposing abundance patterns. This may serve as valuable information for assessing disease risk and treatment outcomes. Future research will focus on the functional analysis of host-microbe and microbe-microbe interactions and the relevance of the host genome for microbiota abundances to identify novel BP treatment approaches.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the German Research Foundation (DFG), through Clinical Research Unit 303, project number 269234613, subproject P2, jointly awarded to Prof. Dr. John F. Baines and Prof. Dr. Dr. Enno Schmidt.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the University of Luebeck ethics committee (15-051, 18-046), as well as the respective committees of the study centers, following the Declaration of Helsinki.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDatasets related to this article have been deposited under BioProject accession number PRJNA715468 at https://www.ncbi.nlm.nih.gov/bioproject/, an open-source online data repository hosted at the NCBI SRA BioProject database. Data are currently available in read-only format at: https://dataview.ncbi.nlm.nih.gov/object/PRJNA715468?reviewer=tpob0l00b03qg88ju4lqnp7dou https://dataview.ncbi.nlm.nih.gov/object/PRJNA715468?reviewer=tpob0l00b03qg88ju4lqnp7dou AbbreviationsAIautoimmuneBPbullous pemphigoidAIBDAutoimmune blistering diseaseEBAEpidermolysis bullosa acquisitaDFdegrees of freedomISindicator speciesASVamplicon sequence variant}, URL = {https://www.medrxiv.org/content/early/2021/05/03/2021.04.30.21256380}, eprint = {https://www.medrxiv.org/content/early/2021/05/03/2021.04.30.21256380.full.pdf}, journal = {medRxiv} }